Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105849

Formation of bile acids in man: conversion of cholesterol into 5β-cholestane-3α,7α,12α-triol in liver homogenates

Ingemar Björkhem, Henry Danielsson, Kurt Einarsson, and Gunnar Johansson

Department of Chemistry, Karolinska Institutet, Stockholm, Sweden

*

Bile acids and steroids 197.

Find articles by Björkhem, I. in: PubMed | Google Scholar

Department of Chemistry, Karolinska Institutet, Stockholm, Sweden

*

Bile acids and steroids 197.

Find articles by Danielsson, H. in: PubMed | Google Scholar

Department of Chemistry, Karolinska Institutet, Stockholm, Sweden

*

Bile acids and steroids 197.

Find articles by Einarsson, K. in: PubMed | Google Scholar

Department of Chemistry, Karolinska Institutet, Stockholm, Sweden

*

Bile acids and steroids 197.

Find articles by Johansson, G. in: PubMed | Google Scholar

Published July 1, 1968 - More info

Published in Volume 47, Issue 7 on July 1, 1968
J Clin Invest. 1968;47(7):1573–1582. https://doi.org/10.1172/JCI105849.
© 1968 The American Society for Clinical Investigation
Published July 1, 1968 - Version history
View PDF
Abstract

The mechanisms of the conversion of cholesterol into bile acids in man were studied by examining the metabolism of cholesterol-1,2-3H, cholest-5-ene-3β,7α-diol-7β-3H, tritiumlabeled 7α-hydroxycholest-4-en-3-one, 7α,12α-dihydroxycholest-4-en-3-one, and cholest-5-ene-3β,7α,12α-triol in fractions of liver homogenates. The 20,000 g supernatant fluid catalyzed the conversion of cholesterol into cholest-5-ene-3β,7α-diol, 7α-hydroxycholest-4-en-3-one, 7α-12α-dihydroxycholest-4-en-3-one, and 5β-cholestane-3α,7α,12α-triol. In the presence of microsomal fraction fortified with NAD+, cholest-5-ene-3β,7α-diol was converted into 7α-hydroxycholest-4-en-3-one, and when this fraction was fortified with NADPH small amounts of cholest-5-ene-3β-7α,12α-triol were formed. 7α-Hydroxycholest-4-en-3-one was metabolized into 7α-12α-dihydroxycholest-4-en-3-one in the presence of microsomal fraction fortified with NADPH and into 5β-cholestane-3α,7α-diol in the presence of 100,000 g supernatant fluid. Cholest-5-ene-3β,7α,12α-triol was converted into 7α,12α-dihydroxycholest-4-en-3-one in the presence of microsomal fraction fortified with NAD+. The 100,000 g supernatant fluid catalyzed the conversion of 7α,12α-dihydroxycholest-4-en-3-one into 5β-cholestane-3α,7α,12α-triol. The sequence of reactions in the conversion of cholesterol into 5β-cholestane-3α,7α-diol and 5β-cholestane-3α,7α,12α-triol, the subcellular localization of the enzymes, and the cofactor requirements were found to be the same as those described for rat liver.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1573
page 1573
icon of scanned page 1574
page 1574
icon of scanned page 1575
page 1575
icon of scanned page 1576
page 1576
icon of scanned page 1577
page 1577
icon of scanned page 1578
page 1578
icon of scanned page 1579
page 1579
icon of scanned page 1580
page 1580
icon of scanned page 1581
page 1581
icon of scanned page 1582
page 1582
Version history
  • Version 1 (July 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts